Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting

被引：0
|
作者：
Gert-Jan Braunstahl
Jan Chlumský
Guy Peachey
Chien-Wei Chen
机构：
[1] Sint Franciscus Gasthuis,Department of Pulmonary Medicine
[2] Charles University,Department of Pulmonary Disease, Thomayer Hospital
[3] Novartis Pharmaceuticals UK Limited,undefined
[4] Novartis Pharmaceuticals Corporation,undefined
来源：
Allergy, Asthma & Clinical Immunology | / 9卷
关键词：
Anti-immunoglobulin E; Oral corticosteroid use; Omalizumab; Registry; Uncontrolled persistent allergic asthma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Braunstahl, Gert-Jan
    Chlumsky, Jan
    Peachey, Guy
    Chen, Chien-Wei
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [2] REDUCTIONS IN EXACERBATIONS IN PATIENTS WITH ALLERGIC (IGE-MEDIATED) ASTHMA RECEIVING OMALIZUMAB IN A REAL-WORLD SETTING
    Kuo, H. P.
    Canvin, J.
    Maykut, R.
    Bruce, J.
    Chen, C. W.
    Braunstahl, G. J.
    [J]. RESPIROLOGY, 2012, 17 : 11 - 11
  • [3] Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
    Szabo, Melinda
    Chlumsky, Jan
    Maykut, Robert
    Georgiou, Panayiotis
    Chen, Chien-Wei
    Peachey, Guy
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] Reductions In Oral Corticosteroid Use In Patients With Allergic (IgE- Mediated) Asthma Receiving Omalizumab
    Braunstahl, G.
    Maykut, R.
    Figliomeni, M.
    Chen, C.
    Peachey, G.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB72 - AB72
  • [5] Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data
    Molimard, M.
    Buhl, R.
    Niven, R.
    Le Gros, V.
    Thielen, A.
    Thirlwell, J.
    Maykut, R.
    Peachey, G.
    [J]. RESPIRATORY MEDICINE, 2010, 104 (09) : 1381 - 1385
  • [6] REAL-WORLD REDUCTION OF ORAL CORTICOSTEROID USE IN PATIENTS TREATED WITH DUPILUMAB AND WITH MODERATE-TO-SEVERE ASTHMA
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. D. P.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [7] Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
    Barthwal, Madhusudan
    Dutta, Vijay
    Bhattacharya, Parthasarthi
    Vora, Agam
    Kotnis, Mangala
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada
    Lee, Jason K.
    Amin, Suvina
    Erdmann, Michelle
    Kukaswadia, Atif
    Ivanovic, Jelena
    Fischer, Aren
    Gendron, Alain
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 725 - 735
  • [9] Real-world effectiveness of dupilumab on oral corticosteroid use in asthma
    Wark, P.
    Pawar, A.
    Blaiss, M.
    Modena, B.
    Khan, A.
    Gomez, De Prado L.
    Pandit-Abid, N.
    Radwan, A.
    Moody, J.
    Jacob-Nara, J.
    [J]. RESPIROLOGY, 2023, 28 : 87 - 88
  • [10] OMALIZUMAB REDUCES MAINTENANCE ORAL CORTICOSTEROID USE IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA
    Niven, R.
    Molimard, M.
    Buhl, R.
    Le Gros, V.
    Thielen, A.
    Thirlwell, J.
    Maykut, R.
    [J]. THORAX, 2009, 64 : A130 - A130
12345